Systemic absorption of oral vancomycin in patients with Clostridium difficile infection

By Rao Sriharsha   Kupfer Yizhak   Pagala Murali   Chapnick Edward   Tessler Sidney  

Scandinavian Journal of Infectious Diseases, Vol. 43, Iss. 5, 2011-05 ,pp. : 386-388

Informa Healthcare

Access to resources Recommend Favorite

Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 9, 2015-05 ,pp. : 835-843

John Wiley & Sons Inc

Access to resources Recommend Favorite

Oral vancomycin may have significant absorption in patients with Clostridium difficile colitis

By Chihara Shingo   Shimizu Riha   Furukata Satoshi   Hoshino Koichi  

Scandinavian Journal of Infectious Diseases, Vol. 43, Iss. 2, 2011-02 ,pp. : 149-150

Informa Healthcare

Access to resources Recommend Favorite

Fidaxomicin versus Vancomycin as a First‐Line Treatment for Clostridium difficile–Associated Diarrhea in Specific Patient Populations: A Pharmacoeconomic Evaluation

By  

PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol. 37, Iss. 12, 2017-12 ,pp. : 1489-1497

John Wiley & Sons Inc

Access to resources Recommend Favorite

Faecal microbiota transplantation plus selected use of vancomycin for severe‐complicated Clostridium difficile infection: description of a protocol with high success rate

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 4, 2015-08 ,pp. : 470-476

John Wiley & Sons Inc

Access to resources Recommend Favorite